Acd-a

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

NOT FOR DIRECT INTRAVENOUS INFUSION

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A)

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), is a sterile, non-pyrogenic solution of citric acid, sodium citrate, and dextrose, in water for injection. Each 10 mL of solution contains:

Manufactured & Distributed by:

Citra Labs™

55 Messina Drive, Braintree, MA 02184

Phone Number: 1-800-299-3411

Authorized Representative:

Biomet Global Supply Chain Center B.V.

Hazeldonk 6530

4836 LD Breda

The Netherlands

It is recommended that the product be stored at ambient room temperature, 24 °C (75 °F); however, the product can be stored between 15 °C (59 °F) and 30 °C (86 °F). Protect from freezing and exposure to excessive heat should be minimized.

• Aseptic technique must be maintained at all times.
• ACD-A solution is a clear and colorless solution. If the product shows any cloudiness or turbidity, the product should be discarded.
• The closure system provides a biological barrier and should be intact – discard product if system is compromised.

Caution: Federal Law (US) restricts this devise to sale by or on the order of a Physician.

NOT FOR DIRECT INTRAVENOUS INFUSION

Long-term studies in animals have not been performed to evaluate the effects of ACD- A on pregnant women.

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP systems in production of platelet rich plasma (PRP).

The safety and effectiveness of ACD-A in children have not been established.

ACD-A acts as an anticoagulant by the action of the citrate ion chelating free ionized calcium, thus making calcium unavailable to the coagulation system.

None.

C E ₀₀₄₄

ACD-A



Anticoagulant Citrate Dextrose Solution,



10 Vials / Case    Solution A, U.S.P., ACD-A, 30 mL

REF PN 9350-10



WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION

Used as an anticoagulant in the extracorporeal blood processing with

Autologous PRP Systems in production of platelet rich plasma (PRP).

Refer to PRP Systems manufacturer's Directions for Use.

Manufactured & Distributed by:

CitraLabs

A Biomet Inc. Company.

Citra Labs, LLC.

55 Messina Drive, Braintree, MA 02184

1-800-299-3411

EC REP



Authorized Representative:

Biomet Global Supply Chain Center B.V.

Hazeldonk 6530

4836 LD Breda

The Netherlands

STERILE • NON-PYROGENIC

Composition per 10 mL of Solution:

Citric Acid, (Anhydrous), U.S.P. 0.073 g.

Sodium Citrate, (Dihydrate), U.S.P. 0.220 g.

Dextrose, (Monohydrate), U.S.P. 0.245 g.

CAUTION: Single Procedure Use-Discard Unused Portion

Do Not Use Unless Solution is Clear and Seal is Intact.

Store Between 15 °C - 30 °C (59 °F - 86 °F).

RX Only:

EXP DATE

LOT

LA9350-10B 01/20

C E ₀₀₄₄

ACD-A



Anticoagulant Citrate Dextrose Solution,



25 Vials / Case    Solution A, U.S.P., ACD-A, 30 mL

REF PN 9350-25



WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION

Used as an anticoagulant in the extracorporeal blood processing with

Autologous PRP Systems in production of platelet rich plasma (PRP).

Refer to PRP Systems manufacturer's Directions for Use.

Manufactured & Distributed by:

CitraLabs

A Biomet Inc. Company.

Citra Labs, LLC.

55 Messina Drive, Braintree, MA 02184

1-800-299-3411

EC REP



Authorized Representative:

Biomet Global Supply Chain Center B.V.

Hazeldonk 6530

4836 LD Breda

The Netherlands

STERILE • NON-PYROGENIC

Composition per 10 mL of Solution:

Citric Acid, (Anhydrous), U.S.P. 0.073 g.

Sodium Citrate, (Dihydrate), U.S.P. 0.220 g.

Dextrose, (Monohydrate), U.S.P. 0.245 g.

CAUTION: Single Procedure Use-Discard Unused Portion

Do Not Use Unless Solution is Clear and Seal is Intact.

Store Between 15 °C - 30 °C (59 °F - 86 °F).

RX Only:

EXP DATE

LOT

LA9350-25 01/20

Long-term studies in animals have not been performed to evaluate the carcinogenic potential of ACD-A.

Manufactured & Distributed by:

Citra Labs™

55 Messina Drive, Braintree, MA 02184

Phone Number: 1-800-299-3411

Authorized Representative:

Biomet Global Supply Chain Center B.V.

Hazeldonk 6530

4836 LD Breda

The Netherlands

It is recommended that the product be stored at ambient room temperature, 24 °C (75 °F); however, the product can be stored between 15 °C (59 °F) and 30 °C (86 °F). Protect from freezing and exposure to excessive heat should be minimized.

• Aseptic technique must be maintained at all times.
• ACD-A solution is a clear and colorless solution. If the product shows any cloudiness or turbidity, the product should be discarded.
• The closure system provides a biological barrier and should be intact – discard product if system is compromised.

Caution: Federal Law (US) restricts this devise to sale by or on the order of a Physician.

NOT FOR DIRECT INTRAVENOUS INFUSION

Long-term studies in animals have not been performed to evaluate the effects of ACD- A on pregnant women.

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP systems in production of platelet rich plasma (PRP).

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), is a sterile, non-pyrogenic solution of citric acid, sodium citrate, and dextrose, in water for injection. Each 10 mL of solution contains:

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A)

The safety and effectiveness of ACD-A in children have not been established.

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

NOT FOR DIRECT INTRAVENOUS INFUSION

ACD-A acts as an anticoagulant by the action of the citrate ion chelating free ionized calcium, thus making calcium unavailable to the coagulation system.

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

None.

Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

C E ₀₀₄₄

ACD-A



Anticoagulant Citrate Dextrose Solution,



10 Vials / Case    Solution A, U.S.P., ACD-A, 30 mL

REF PN 9350-10



WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION

Used as an anticoagulant in the extracorporeal blood processing with

Autologous PRP Systems in production of platelet rich plasma (PRP).

Refer to PRP Systems manufacturer's Directions for Use.

Manufactured & Distributed by:

CitraLabs

A Biomet Inc. Company.

Citra Labs, LLC.

55 Messina Drive, Braintree, MA 02184

1-800-299-3411

EC REP



Authorized Representative:

Biomet Global Supply Chain Center B.V.

Hazeldonk 6530

4836 LD Breda

The Netherlands

STERILE • NON-PYROGENIC

Composition per 10 mL of Solution:

Citric Acid, (Anhydrous), U.S.P. 0.073 g.

Sodium Citrate, (Dihydrate), U.S.P. 0.220 g.

Dextrose, (Monohydrate), U.S.P. 0.245 g.

CAUTION: Single Procedure Use-Discard Unused Portion

Do Not Use Unless Solution is Clear and Seal is Intact.

Store Between 15 °C - 30 °C (59 °F - 86 °F).

RX Only:

EXP DATE

LOT

LA9350-10B 01/20

C E ₀₀₄₄

ACD-A



Anticoagulant Citrate Dextrose Solution,



25 Vials / Case    Solution A, U.S.P., ACD-A, 30 mL

REF PN 9350-25



WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION

Used as an anticoagulant in the extracorporeal blood processing with

Autologous PRP Systems in production of platelet rich plasma (PRP).

Refer to PRP Systems manufacturer's Directions for Use.

Manufactured & Distributed by:

CitraLabs

A Biomet Inc. Company.

Citra Labs, LLC.

55 Messina Drive, Braintree, MA 02184

1-800-299-3411

EC REP



Authorized Representative:

Biomet Global Supply Chain Center B.V.

Hazeldonk 6530

4836 LD Breda

The Netherlands

STERILE • NON-PYROGENIC

Composition per 10 mL of Solution:

Citric Acid, (Anhydrous), U.S.P. 0.073 g.

Sodium Citrate, (Dihydrate), U.S.P. 0.220 g.

Dextrose, (Monohydrate), U.S.P. 0.245 g.

CAUTION: Single Procedure Use-Discard Unused Portion

Do Not Use Unless Solution is Clear and Seal is Intact.

Store Between 15 °C - 30 °C (59 °F - 86 °F).

RX Only:

EXP DATE

LOT

LA9350-25 01/20

Long-term studies in animals have not been performed to evaluate the carcinogenic potential of ACD-A.